fbpx
Elias Sayour, MD, PhD

CureSearch for Children’s Cancer receives gift to support promising immunotherapy trial

CureSearch for Children’s Cancer receives $1 million gift from Norcross Family Foundation Funds to support cutting-edge immunotherapy trial for pediatric high-grade glioma  Bethesda, MD – February 8, 2020  – CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing an innovative personalized …

CureSearch for Children’s Cancer receives gift to support promising immunotherapy trial Read More »

Delivering measurable results in the form of new treatment options for children today

By Caitlyn Barrett, PhD – CureSearch National Director of Research & Programs At CureSearch, we’re focused on driving the most innovative new therapies towards clinical trials where they’ll directly impact children in treatment today. Simply put, if a project can’t reach the clinic in an accelerated timeframe, we don’t fund it. Our strategy is unique, and …

Delivering measurable results in the form of new treatment options for children today Read More »

An Innovative Treatment Approach for DIPG: CureSearch for Children’s Cancer Partners with SebastianStrong Foundation to Fund Promising New Research

Contact: Tiffani CopelandSenior Vice President, Development & CommunicationsCureSearch for Children’s CancerEmail: tiffani.copeland@curesearch.org Bethesda, MD – July 30, 2020 – CureSearch for Children’s Cancer, in partnership with the SebastianStrong Foundation, has awarded a $225,000 Young Investigator grant to Yale Cancer Center’s Dr. Ranjith Menon Muraleedharan, who will develop a new treatment approach for diffuse intrinsic pontine …

An Innovative Treatment Approach for DIPG: CureSearch for Children’s Cancer Partners with SebastianStrong Foundation to Fund Promising New Research Read More »

CureSearch Research Addresses Critical Unmet Need For Safe, Effective Pediatric Brain Cancer Treatments

CureSearch Research Funding DrivesNew Brain Cancer Treatments May is National Brain Tumor Awareness Month, highlighting a critical topic in the childhood cancer community as brain cancers account for 25% of all childhood and adolescent cancer diagnoses. Brain tumor types include medulloblastoma (the most common), high- and low-grade glioma, Primitive Neuro-Ectodermal Tumor (PNET), and ependymoma. At CureSearch, we’re dedicated to supporting families affected by brain cancer and to …

CureSearch Research Addresses Critical Unmet Need For Safe, Effective Pediatric Brain Cancer Treatments Read More »

Volunteer Week 2020

National Volunteer Week Spotlight: Industry Advisory Council champions pediatric drug development from within

As we work to find new and less-toxic treatments for pediatric cancers, we know that smarter research funding is just one part of the solution. Long-term solutions require a seismic shift in the existing pediatric drug development process. This change demands the strategic collaboration of all the players in the pediatric cancer ecosystem, including science, …

National Volunteer Week Spotlight: Industry Advisory Council champions pediatric drug development from within Read More »

Seymour Grant

CureSearch Announces $2.5 Million Grant Supporting First-In-Human Clinical Trial For Pediatric High-Grade Glioma Treatment

Promising immunotherapy addresses lack of effective treatments for deadly brain tumors Media Contact: Tiffani Copeland Vice President, Campaign Development & Communications CureSearch for Children’s Cancer Email: tiffani.copeland@curesearch.org Phone: (800) 458-6223 Bethesda, MD – March 30, 2020 – CureSearch for Children’s Cancer has committed $2.5 million to fund a first-in-human, phase I/II clinical trial testing an innovative …

CureSearch Announces $2.5 Million Grant Supporting First-In-Human Clinical Trial For Pediatric High-Grade Glioma Treatment Read More »

Coronavirus COVID-19

COVID-19 Impact and Action

Updated 5/1/20 To the CureSearch Community: Like you, we’re closely monitoring the evolving situation surrounding COVID-19. With the safety of our patient families, volunteers and staff top of mind, all CureSearch-sponsored events through June 1st have been postponed, including our annual CureSearch Summit and spring Ultimate Hike events. We hope that you’ll continue to participate …

COVID-19 Impact and Action Read More »

Kathryn Lemberg, MD, PhD

Dr. Kathryn Lemberg, CureSearch Young Investigator Award: MPNST

Dr. Kathryn Lemberg – Johns Hopkins University CureSearch Young Investigator Award: 2019-2021 Focus: Malignant Peripheral Nerve Sheath Tumor  Project Title: JHU395: A glutamine antagonist for malignant peripheral nerve sheath tumor Project Overview: Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive tumors that arise from the cells that normally support nerve function. Most cases are seen …

Dr. Kathryn Lemberg, CureSearch Young Investigator Award: MPNST Read More »

CureSearch for Children's Cancer

CureSearch Announces $450,000 in New Research Funding to Drive Innovative Treatments for Pediatric Neuroblastoma and MPNST

Contact:Tessa Gatz, Director of Communications, CureSearch for Children’s CancerPhone: (240) 235-2204  |  tessa.gatz@curesearch.org Bethesda, MD – October 28, 2019 – CureSearch for Children’s Cancer is proud to announce funding for two CureSearch Young Investigator Awards supporting promising new therapies for pediatric neuroblastoma and malignant peripheral nerve sheath tumor (MPNST). Each project will receive $225,000 over three years …

CureSearch Announces $450,000 in New Research Funding to Drive Innovative Treatments for Pediatric Neuroblastoma and MPNST Read More »

Pin It on Pinterest

Scroll to Top